VZV IgG, IgM and IgA antibodies (varicella-zoster)
This ArminLabs panel measures IgG, IgA and IgM antibodies to varicella-zoster virus (VZV) by ELISA. VZV causes chickenpox. After that first infection it stays dormant in the nerves and can reactivate later as shingles (herpes zoster).
What the results are used for:
- Checking immunity: a positive IgG usually means protection from past chickenpox or vaccination. It is often checked before pregnancy, transplant or work in healthcare.
- Supporting a diagnosis of recent infection or reactivation, together with symptoms.
How to read the results:
- IgG positive and IgM negative is the usual pattern of past immunity.
- IgM or IgA can rise in a first infection and sometimes in shingles, but neither reliably separates the two.
- A negative IgG does not rule out immunity from vaccination, because standard tests can miss vaccine antibodies. Check vaccination records too. Early infection can also test negative.
For an active rash, a PCR swab of the blisters is the preferred test.
Biomarkers in this category
3 biomarkers · optimal ranges shown
The VZV IgG ELISA detects long-lasting antibodies to varicella-zoster and is reported as Positive/Negative (sometimes Equivocal or an index). Positive usually means immunity from past infection or vaccination, but it doesn’t diagnose an active rash or date exposure. Negative suggests no documented immunity or testing too early after vaccination/exposure; antibodies often appear within 2–3 weeks, so retest in 2–6 weeks if timing is close. Suspected chickenpox or shingles should be confirmed with PCR from lesions, not IgG. Consider immune-status documentation for pregnancy, immunosuppression, and occupational settings. IgM isn’t recommended due to false positives. Always use your lab’s reference ranges for final interpretation.